Bangor Savings Bank lessened its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 13.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,303 shares of the semiconductor company’s stock after selling 198 shares during the quarter. Bangor Savings Bank’s holdings in Synopsys were worth $632,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Hazlett Burt & Watson Inc. raised its holdings in Synopsys by 40.0% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $35,000 after purchasing an additional 20 shares in the last quarter. Green Alpha Advisors LLC raised its stake in Synopsys by 1.7% in the third quarter. Green Alpha Advisors LLC now owns 1,294 shares of the semiconductor company’s stock worth $655,000 after buying an additional 22 shares in the last quarter. Aptus Capital Advisors LLC lifted its holdings in Synopsys by 1.5% in the third quarter. Aptus Capital Advisors LLC now owns 1,447 shares of the semiconductor company’s stock worth $733,000 after buying an additional 22 shares during the period. Resurgent Financial Advisors LLC boosted its position in Synopsys by 2.8% during the 3rd quarter. Resurgent Financial Advisors LLC now owns 809 shares of the semiconductor company’s stock valued at $410,000 after acquiring an additional 22 shares in the last quarter. Finally, Larson Financial Group LLC grew its holdings in shares of Synopsys by 6.1% during the 3rd quarter. Larson Financial Group LLC now owns 398 shares of the semiconductor company’s stock worth $202,000 after acquiring an additional 23 shares during the period. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Analyst Ratings Changes
SNPS has been the topic of several research reports. Needham & Company LLC restated a “buy” rating and set a $640.00 price target on shares of Synopsys in a research report on Thursday, December 5th. Robert W. Baird dropped their target price on shares of Synopsys from $644.00 to $630.00 and set an “outperform” rating on the stock in a report on Thursday, December 5th. Wells Fargo & Company assumed coverage on shares of Synopsys in a research note on Friday, November 22nd. They issued an “equal weight” rating and a $570.00 price target for the company. Loop Capital started coverage on shares of Synopsys in a research note on Monday, November 11th. They set a “buy” rating and a $675.00 price objective on the stock. Finally, Berenberg Bank initiated coverage on shares of Synopsys in a research note on Tuesday, October 15th. They set a “buy” rating and a $660.00 target price for the company. One equities research analyst has rated the stock with a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $649.00.
Synopsys Price Performance
Shares of NASDAQ:SNPS opened at $501.06 on Tuesday. The stock’s fifty day moving average price is $525.85 and its 200-day moving average price is $531.85. The company has a market cap of $77.45 billion, a P/E ratio of 34.51, a PEG ratio of 3.41 and a beta of 1.12. Synopsys, Inc. has a 1 year low of $457.52 and a 1 year high of $629.38.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories
- Five stocks we like better than Synopsys
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- 2 Gene-Editing Stocks Positioned for a Strong Comeback in 2025
- Insider Buying Explained: What Investors Need to Know
- Will Berkshire Hathaway Continue to Dominate in 2025?
- What is a Special Dividend?
- 2 Agriculture Stocks To Benefit From a Trump Presidency in 2025
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.